Clinical Trial Update: Micellar Curcumin and Metabolic Syndrome Biomarkers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating micellar curcumin for metabolic syndrome has completed; the available update does not include efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Micellar Curcumin (curcumin)

Snippet

Sponsor: University of Hohenheim | Conditions: Metabolic Syndrome, Protection Against | Phase 2 | Status: COMPLETED